Ultragenyx Pharmaceutical | RARE - Market Capitalization


Ultragenyx Pharmaceutical reported $1.11B in Market Capitalization this September of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Acadia Pharmaceuticals USD 4.33B 537M Jun/2026
Alnylam Pharmaceuticals USD 40.19B 3.96B Jun/2026
BioCryst Pharmaceuticals USD 2.54B 880M Jun/2026
BioMarin Pharmaceutical USD 11.06B 196M Jun/2026
Immunic USD 64M 23M Dec/2025
Insmed USD 23.11B 12.19B Jun/2026
Ionis Pharmaceuticals USD 13.1B 642M Jun/2026
Karyopharm Therapeutics USD 126M 9M Mar/2026
Kyowa Hakko Kirin JPY 1.36T 4.73B Jun/2026
MacroGenics USD 184M 82M Mar/2026
Neurocrine Biosciences USD 16.95B 3.7B Jun/2026
Regeneron Pharmaceuticals USD 65.37B 16.31B Jun/2026
Sarepta Therapeutics USD 1.9B 388M Jun/2026
Ultragenyx Pharmaceutical USD 3.29B 1.23B Jun/2026
Vertex Pharmaceuticals USD 126.07B 12.49B Jun/2026